drugset / Trial / NCT00092508
CORE: A Study of OPC-6535 With Asacol® in Maintaining Ulcerative Colitis (UC) Remission
RandomizedParallel-groupDouble-blindTreatment
Summary
This dose comparison study, taking place at over 200 sites worldwide, will compare the dosing, safety and efficacy of an investigational medicine OPC-6535 to the dosing, safety and efficacy of Asacol ® in the maintenance of remission in subjects with ulcerative colitis.
Timeline
- Start
- 2004-05
- Primary completion
- —
- Completion
- 2007-05
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Mesalamine | Small molecule | 800 mg | — |
| Subject | Tetomilast | Small molecule | 25 mg | — |
| Subject | Tetomilast | Small molecule | 50 mg | — |